DENTSPLY International, York, Pa, and GlaxoSmithKline have entered into an agreement to create a portfolio of co-branded oral care products to be used in the dental office by patients suffering from tooth sensitivity.

In December 2009, GSK acquired NovaMin® through the purchase of NovaMin Technology Inc. NovaMin is a patent-protected calcium phosphate technology that has been clinically proven to relieve tooth sensitivity. The new agreement will allow DENTSPLY to co-brand its NUPRO® products, which contain the NovaMin technology, with GSK’s Sensodyne® brand.

The agreement also provides for the use of both companies’ technical, clinical, and marketing resources to offer a range of tooth-sensitivity treatment options for the dental professional and the patient. In the short term, DENTSPLY will release two co-branded dental products containing NovaMin technology: NUPRO Sensodyne Professional prophy paste and Sensodyne NUPRO Professional toothpaste (a toothpaste to be dispensed by dental professionals).

For more information on these and other orthodontic companies, visit our Buyer’s Guide.